Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-017306
Filing Date
2016-05-02
Accepted
2016-05-02 16:30:50
Documents
69
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q prtk-10q_20160331.htm 10-Q 1195714
2 EX-31.1 prtk-ex311_10.htm EX-31.1 18163
3 EX-31.2 prtk-ex312_6.htm EX-31.2 18325
4 EX-32.1 prtk-ex321_7.htm EX-32.1 6738
5 EX-32.2 prtk-ex322_9.htm EX-32.2 6865
  Complete submission text file 0001564590-16-017306.txt   5433174

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT prtk-20160331.xml EX-101.INS 1098354
7 XBRL TAXONOMY EXTENSION SCHEMA prtk-20160331.xsd EX-101.SCH 54139
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prtk-20160331_cal.xml EX-101.CAL 45930
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prtk-20160331_def.xml EX-101.DEF 180403
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE prtk-20160331_lab.xml EX-101.LAB 400325
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prtk-20160331_pre.xml EX-101.PRE 300749
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Filer) CIK: 0001178711 (see all company filings)

EIN.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36066 | Film No.: 161612034
SIC: 2834 Pharmaceutical Preparations